DGAP-News: GMI Global Medical Investors Aktiengesellschaft: GMI AG strenghtens market position inside German healthcare market
(firmenpresse) - GMI Global Medical Investors Aktiengesellschaft / Acquisition/Mergers&Acquisitions
01.03.2010 08:00
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
GMI Global Medical Investors AG
Munich, March 1st, 2010
New GMI daughter implements the build-up of supporting medical therapy
institutions for selected German Medical Fraternities for the treatment of
planned prospective 200.000 chronically ill patients in Germany, providing
for approximately up to 2.000 new jobs.
In line with the already implemented and registered capital increase of GMI
Global Medical Investors AG (GMI AG), IMP International Medical Partners
GmbH&Co KG has been subject to a 100 % take-over by GMI AG.
IMP GmbH&Co KG specializes on the acquisition of shareholdings of
companies in the fields of marketing and distribution inside the new German
healthcare market.
Besides the new German Healthcare Brand 'BMT Bio Medizinisches
Therapiezentrum' also the DMF Deutsche Medical Franchise GmbH&Co KG
belongs to IMP GmbH&Co KG, now acquired by GMI AG.
Inside the boundaries of the currently newly developing and re-structuring
German healthcare market DMF GmbH&Co KG develops franchise- and
distribution concepts and medical networks for the medical profession.
Under the roof of the brand name BMT, DMF GmbH&Co KG is building up to
200 institutional BMT Bio Medizinisches Therapie Zentrum nationwide in the
standardized BMT system, in service for the resident medical profession.
Inside the BMT cooperating resident doctors can perform highly efficient
and cutting edge quality therapies for public- and private healthcare
patients, as well as self-paying patients, right at their doorstep.
Usually a regular representative of the resident medical profession is not
in the position to master the investment going along with the
implementation of such modern medical installments.
Suffering from governmental income cuts and rising costs, the resident
doctor would have to risk high-level investments while facing the difficult
challenge having to amortize the investment all by himself.
The BMT Zentrum, equipped with such high-level technical standard, provides
supporting therapies inside the medical treatment chain in the areas of
Dermatology, Orthopedy, Rheumatism, illnesses in the area of Psychosomatic.
Due to consolidation of therapies in one large BMT Centrum, healthcare
system, patients and the resident medical profession profit from the
resulting savings.
While BMT professionally informs the market using integrative marketing,
distribution and public relations activities, the cooperating resident
doctors ensure the high-level medical quality standard in all BMT Centers.
After the successful completion of the planned build up of app.
200 BMT Centers, up to 2,000 new jobs shall be provided for and app.
200.000 chronically ill patients annually shall be able to receive regular
treatment, eliminating the current standard, where, due to absence of
availability of adequate nationwide treatment possibilities, limited or no
pointed support can be provided.
About GMI Global Medical Investors AG:
Founded in 2009, GMI Global Medical Investors AG is a listed investment
company based in Munich, Germany. GMI AG's investments focus on the rapidly
changing and growing international healthcare market. GMI AG invests in
companies that are well positioned with marketable products and services,
offering stable growth potential within the value chain in the primary
healthcare market. To realize these actions GMI AG uses either own capital,
or operates, depending upon demand and necessity, with individually
tailor-made institutional and private investment pools, aiming specifically
at the before mentioned targeted platform.
The overall aim of GMI Global Medical Investors AG is the value increase of
the participations on a strictly sustainable basis and a partnership
limited in time.
GMI AG operates on grounds of a realistically accessible and timely limited
exit strategy. GMI AG has a share capital of 12,434 Million EUR at its
disposal, divided up into 12,434 Million pieces of bearer common shares.
Shares of GMI AG have been listed on the Frankfurt Stock Exchange (Open
Market) since January 13, 2010 (ISIN DE000A1A6ZU5).
GMI Global Medical Investors AG
Contact: Frank Michael Gaw
Theresienstrasse 40
80333 Munich
-Germany-
E-mail: info(at)gmi-ag.com
Telephone: +49-89-52011464
Fax: +49-89-52011465
www.gmi-ag.com
Important information:
This communication is neither an offer to sell nor a request to make an
offer to sell securities in Germany and is not an offering prospectus
within the meaning of the Wertpapierprospektgesetz (German Securities
Offering Prospectus Act), the EU directive by the Commission No. 809/2004
dated April 29, 2005 or other legal provisions which apply in Germany which
regulate the issue, the offering and the sale of securities.
The information included in this announcement is not designated for
dissemination to the United States of America or within the United States
of America.
The information included in this announcement is not for publication nor
for dissemination in Canada, Australia or Japan, and does not constitute an
offer for the purchase of securities in these countries.
The placement of shares and the distribution of this announcement and other
information in connection with the placement in certain legislative
jurisdictions can be subject to statutory restrictions and those persons
who gain possession of the documents named in this announcement should
obtain their own information on all such restrictions and uphold these. Any
failure to uphold these restrictions can constitute a violation of
securities trading acts in the respective legislative jurisdictions.
01.03.2010 08:00 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv atwww.dgap-medientreff.deandwww.dgap.de---------------------------------------------------------------------------
Datum: 01.03.2010 - 08:00 Uhr
Sprache: Deutsch
News-ID 17122
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 530 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: GMI Global Medical Investors Aktiengesellschaft: GMI AG strenghtens market position inside German healthcare market"
steht unter der journalistisch-redaktionellen Verantwortung von
GMI Global Medical Investors Aktiengesellschaft (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
